TITLE

Combating HIV in the first weeks of infection may be crucial

AUTHOR(S)
Delaney, Martin
PUB. DATE
June 1992
SOURCE
Advocate;6/2/92, Issue 604, p31
SOURCE TYPE
Periodical
DOC. TYPE
Article
ABSTRACT
Presents news items related to AIDS in the U.S. for the week of June 2, 1992. Discussion of the anti-AIDS drugs ddI and ddC at a Food and Drug Administration committee meeting; Comparison of AZT to the drugs; Reforms to achieve faster drug-approval procedures; Planned national march against AIDS; Early treatment of HIV infections.
ACCESSION #
9673117

 

Related Articles

  • AIDS Vaccine Conference. Rockwood, Kate // Fast Company;Sep2011, Issue 158, p25 

    A timeline is presented of events following the first diagnosis of HIV 30 years ago, including the identification of the virus that causes AIDS, the first antiretroviral drug to become available for HIV treatment, called AZT, and the first phase III testing of an AIDS vaccine, AIDSVAX by VaxGen.

  • Is There A Cure For AIDS?  // Public Health Reports;May/Jun88, Vol. 103 Issue 3, p333 

    The article reveals that presently. there is no cure for AIDS. Medicines such as AZT have prolonged the lives of some patients with AIDS. There is no vaccine to prevent uninfected people from getting AIDS. The article reports that it may take years for an effective, safe vaccine to be found. It...

  • Zidovudine.  // AHFS Consumer Medication Information;Jun2020, p1 

    Zidovudine is used alone or with other medications to treat human immunodeficiency virus (HIV) infection in patients with or without acquired immunodeficiency syndrome (AIDS). It will slow the spread of HIV infection in the body. Zidovudine is not a cure and may not decrease the number of...

  • Emerging Concepts in the Treatment of HIV Infection in Children. Pizzo, Philip A. // JAMA: Journal of the American Medical Association;10/13/89, Vol. 262 Issue 14, p1989 

    Discusses concepts in the treatment of HIV infection in children. Focus on the case of a 16-month-old child who was diagnosed with HIV infection at four months of age when she developed acute interstitial pneumonia; HIV seropositive condition of the mother; Epidemiology of HIV; HIV...

  • A Randomized Trial of Simplified Maintenance Therapy with Abacavir, Lamivudine, and Zidovudine in Human Immunodeficiency Virus Infection. Opravil, Milos; Hirschel, Bernard; Lazzarin, Adriano; Furrer, Hansjakob; Chave, Jean-Philippe; Yerly, Sabine; Bisset, Leslie R.; Fischer, Marek; Vernazza, Pietro; Bernasconi, Enos; Battegay, Manuel; Ledergerber, Bruno; G√ľnthard, Huldrych; Howe, Colin; Weber, Rainer; Perrin, Luc // Journal of Infectious Diseases;5/1/2002, Vol. 185 Issue 9, p1251 

    This randomized study evaluated the efficacy and tolerability of continued treatment with protease inhibitor plus nucleoside-analogue combination regimens (n = 79) or a change to the simplified regimen of abacavir-lamivudine-zidovudine (n = 84) in patients with suppressed human immunodeficiency...

  • MEDICAL BRIEFS. Cohan, Gary R. // Advocate;9/7/93, Issue 637, p39 

    Presents news concerning AIDS as of September 1993. Ban on the sale of HIV tests in France; Role of AZT in HIV infection; Analysis of AIDS research in the U.S.

  • Brighter future. Day, Michael // New Scientist;02/28/98, Vol. 157 Issue 2123, p13 

    Reports that if mothers take the anti-AIDS drug Azidothymidine (AZT) in the final month of pregnancy, they reduce the risk of passing the human immunodeficiency virus (HIV) to their babies. Information from Joseph Saba, head of the UNAIDS Working Group on the Preventition of Mother to Child HIV;...

  • Zidovudine. Smith, Mark D. // JAMA: Journal of the American Medical Association;11/20/91, Vol. 266 Issue 19, p2750 

    Editorial. Talks about the effectiveness of zidovudine in minorities with acquired immunodeficiency syndrome. Studies which show the efficacy of zidovudine; Import features shared by both studies.

  • Combination Therapy for HIV Infection: Getting Closer. Fanci, Anthony S. // Annals of Internal Medicine;1/1/92, Vol. 116 Issue 1, p85 

    Editorial. Comments on issues regarding combination therapy with antiretroviral agents for HIV infection in the U.S. as of January 1992. Observations on research in combination therapy; Views on the use of zidovudine for HIV treatment; Insights on the role of surrogate markers.

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics